Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.
Reducing off-label use of antipsychotic medications may save money
- Share:
First published by
via | May 17, 2012
| Science & Technology |
0 responses
